Evaluation Study of HCV RDTs in Fresh Samples

CompletedOBSERVATIONAL
Enrollment

1,540

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

March 31, 2020

Conditions
Hepatitis C Virus Infection
Interventions
DIAGNOSTIC_TEST

Test for HCV antibodies with an RDT

Fingerstick whole blood, plasma and serum of each participant is tested with three investigational HCV RDTs and one reference HCV RDT. Plasma is also used for testing with the composite reference standard, HCV viral load and genotyping. All participants are also tested for HIV with an HIV RDT.

Trial Locations (2)

Unknown

Sihanouk Hospital Centre of Hope, Phnom Penh

0198

National Center for Disease Control & Public Health/Lugar Center, Tbilisi

All Listed Sponsors
collaborator

Institute of Tropical Medicine, Belgium

OTHER

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT04139941 - Evaluation Study of HCV RDTs in Fresh Samples | Biotech Hunter | Biotech Hunter